| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/18/2002 | WO2001057215A3 Human g-protein coupled receptor polypeptides and polynucleotides having homology with odorant receptors |
| 04/18/2002 | WO2001057073A3 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 04/18/2002 | WO2001055214A3 Asthma-associated gene |
| 04/18/2002 | WO2001051632A3 Odorant receptor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2001051631A3 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001049743A3 Methods of modulation of the immune system |
| 04/18/2002 | WO2001049712A3 Vaccine against isav (infectious salmon anaemia virus) |
| 04/18/2002 | WO2001048179A3 Binding of polyamides to proteins having sh3 or ww domains |
| 04/18/2002 | WO2001046262A3 Olfactory receptor genes and pseudogenes in primates and mouse |
| 04/18/2002 | WO2001046226A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001036464A3 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 04/18/2002 | WO2001032684A3 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 04/18/2002 | WO2001027277A3 Proteins and polynucleotides encoded thereby |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2001024832A3 Pharmaceutical composition for treating and preventing human tumors, which express the tumor antigen mucin and/or the carcinoembryonic antigen (cea), and the use thereof |
| 04/18/2002 | WO2000075184A9 Modulation of protein levels using the scf complex |
| 04/18/2002 | WO2000071752A9 Assay for the detection of paclitaxel resistant cells in human tumors |
| 04/18/2002 | WO2000071722A9 Novel genes to control flowering, transgenic plants, and uses thereof |
| 04/18/2002 | WO2000070044A9 Human brain t calcium channel alpha-subunit splice variants |
| 04/18/2002 | WO2000068387A9 Nucleic acids and proteins with interferon-beta activity |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | WO2000055192A3 Hemocyanin and nucleic acid sequence coding for the same |
| 04/18/2002 | US20020046419 Introducing an engineered zinc finger polypeptide in said plant cell which polypeptide binds to the target DNA and modulates transcription of the coding sequence |
| 04/18/2002 | US20020046418 In transgenic plants transformed with an expression vector comprising a controlled environment agriculture (CEA) promoter operably linked to a gene encoding the heterologous protein of interest, to maximize heterologous protein production |
| 04/18/2002 | US20020046417 Development of resistance to raspberry bushy dwarf virus |
| 04/18/2002 | US20020046416 Plant proteins |
| 04/18/2002 | US20020046415 Plant promoter sequences and methods of use thereof |
| 04/18/2002 | US20020046413 Transgenic mice containing BMP gene disruptions |
| 04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
| 04/18/2002 | US20020046409 Roles for Nkx3.1 in prostate development and cancer |
| 04/18/2002 | US20020045839 Transmission assembly for a surgical biopsy device |
| 04/18/2002 | US20020045764 Tubulin binding compounds (COBRA) |
| 04/18/2002 | US20020045743 Novel human membrane proteins and polynucleotides encoding the same |
| 04/18/2002 | US20020045742 Dna encoding a gaba b r2 polypeptide and uses thereof |
| 04/18/2002 | US20020045741 Novel haemopoietin receptor and genetic sequence encoding same |
| 04/18/2002 | US20020045740 Novel human 7TM proteins and polynucleotides encoding the same |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045735 Isolating glycoproteins from solution; obtain sample, homogenize, incubate with acetic acid, recover preferential glycoproteins |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045733 Mammalian cytokine-like receptor 5 |
| 04/18/2002 | US20020045731 Adjusted insulin for use in the treatment of diabetes |
| 04/18/2002 | US20020045592 Genes identified as required for proliferation in escherichia coli |
| 04/18/2002 | US20020045591 For gene therapy including polynucleotide sequences encoding peptides including beta-catenin binding domains such as cadherins, for treating cancers with abnormally high levels of beta-catenin |
| 04/18/2002 | US20020045590 Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors |
| 04/18/2002 | US20020045589 Hirulogs are a group of synthetic thrombin-specific inhibitors which conserve the major active sites of hirudin; treatment of vascular restenosis |
| 04/18/2002 | US20020045582 Stabilized protein crystals formulations containing them and methods of making them |
| 04/18/2002 | US20020045579 Modulation of inflammation related to columnar epithelia |
| 04/18/2002 | US20020045578 Tumor necrosis factor receptor 1 death domain (TNFR-1 DD); using structure to identify inhibitors to TNFR-1 DD; computer analysis based drug screening |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045576 Novel neurotrophic factor |
| 04/18/2002 | US20020045573 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury |
| 04/18/2002 | US20020045568 Use of mp52 0r mp121 for treating and preventing diseases of the nervous system |
| 04/18/2002 | US20020045567 Synthetic proteins for in vivo drug delivery and tissue augmentation |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045255 Method of making glycoprotein exhibiting erythropoiesis regulating activity and glycoprotein produced by this method |
| 04/18/2002 | US20020045249 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 04/18/2002 | US20020045248 Intracellular inhibitors of gq protein signaling |
| 04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
| 04/18/2002 | US20020045240 Solid phase extraction of the sources containing the components to be separated on anion exchanger materials in loose bulk, on membranes and/or on compact disks,removal of effluent; elution of adsorbed material, fractionation |
| 04/18/2002 | US20020045231 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 04/18/2002 | US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 04/18/2002 | US20020045223 Microorganism for use in the generation of preferential amino acid in culture |
| 04/18/2002 | US20020045218 Nucleotide sequences coding fusion protein for use in the diagnosis and prevention of bacterial infections |
| 04/18/2002 | US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 04/18/2002 | US20020045216 Nucleotide sequences coding binding protein; for use in treatment of infections, pain, cancers, diabetes, dietetics, eating disorders, asthma, heart defects, parkinson's, osteoporosis, and nervous system and psychological disorders |
| 04/18/2002 | US20020045215 Isolation and characterization of a rat epidermal growth factor related protein |
| 04/18/2002 | US20020045214 Rat G-protein coupled receptor AXOR29 |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045212 Nucleotide sequences coding preferential polypeptides for use in the treatment of alzheimer's, parkinson's, autoimmune, psoraisis, leukemia, infections, and skin disorders |
| 04/18/2002 | US20020045211 Plasmid for use in the generation of genetically engineered amino acid sequences |
| 04/18/2002 | US20020045210 Nucleotide sequences coding preferential protein; for use as diagnostic tool in the treatment and prevention of defects in pituitary tissues, testis and spleen; antitumor agents |
| 04/18/2002 | US20020045209 Nucleotide sequences coding membrane proteins for treatment of central nervous system disorder |
| 04/18/2002 | US20020045208 Nucleotide sequences which code polypeptides for use in treatment of autoimmune diseases, allergies and tumors |
| 04/18/2002 | US20020045206 Contacting the cells with a trophic amount of a ptc therapeutic for promoting survival of substantia nigra neuronal cells |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045197 Methods of determining protein activity levels using gene expression profiles |
| 04/18/2002 | US20020045194 Proteomic analysis |
| 04/18/2002 | US20020045193 Polypeptide for use in purifying and separation of target peptides |
| 04/18/2002 | US20020045192 Detection of perferential complex formation in sample; incubate ligand with cell cycle regulatory protein, detect complex formation in sample |
| 04/18/2002 | US20020045187 Methods and compositions for stimulating the immune system |
| 04/18/2002 | US20020045186 Inhibition of protein binding to mast cells |
| 04/18/2002 | US20020045173 GLP-2 receptor gene promoter and uses thereof |
| 04/18/2002 | US20020045170 Polynucleotides encoding novel secreted proteins |
| 04/18/2002 | US20020045166 Peptides; for use as tools in gene therapy |
| 04/18/2002 | US20020045165 Detecting target nucleotide sequences in sample; obtain sample, incubate sample with preferential nucleotides, detect bound sequences, classify sample |
| 04/18/2002 | US20020045164 Reagents and methods useful for detecting diseases of the lung |
| 04/18/2002 | US20020044952 Attenuated live neospora vaccine |
| 04/18/2002 | US20020044951 Isolated and purified nonpeptide antigens from mycobacterium tuberculosis |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044949 Use in vaccination for preventing or treating Helicobacter infection |
| 04/18/2002 | US20020044948 Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| 04/18/2002 | US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines |
| 04/18/2002 | US20020044945 Novel feline immunodeficiency virus nucleotide sequence |
| 04/18/2002 | US20020044944 DNA encoding the polypeptide, with at least one deletion in the amino acid sequence; expression vectors; host cells; higher apoptosis activity |
| 04/18/2002 | US20020044941 Nucleic acids, proteins and antibodies |
| 04/18/2002 | US20020044939 Or Escherichia coli (E. coli) heat labile toxin where in the amino acid sequence, serine-63 and arginine-192 are replaced by another amino acid; vaccines against Vibrio cholera and enterotoxigenic strain of E. coli |
| 04/18/2002 | US20020044938 Compositions and methods for the treatment of inflammatory bowel disease |